Clinical Trials Arena January 23, 2024
Joshua Silverwood

The study was designed to assess the equivalence of visual acuity measurements between Tilak Healthcare’s OdySight app, and traditional eyesight checks.

French digital health firm, Tilak Healthcare, has announced positive results from a clinical trial of a mobile app aimed at allowing patients with chronic macular degeneration to monitor their eyesight.

TIL002, a multicentre trial taking place across three French hospitals, demonstrated that theCE-marked OdySight app showed a high level of concordance between itself and traditional methods of testing for eyesight decline.

The app allows patients to carry out regular monitoring of their visual acuity through eye tests that they perform themselves, with the results forwarded to the patient’s clinicians.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Apps, Biotechnology, Clinical Trials, Digital Health, Pharma, Pharma / Biotech, Technology, Trends
OpenAI Launches ChatGPT Support for More Apple Desktop Apps
Every Choice Matters: Data Security And Privacy On AI-Enabled Apps
10 New AI Apps That Deserve Your Attention
AI-enabled apps top ECRI’s list of health tech hazards in 2025
Opinion: Mental health apps need a complete redesign

Share This Article